{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P25054",
      "entity_text" : "APC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Our observations provide evidence that APC attenuates fetal neuroinflammation and the associated secondary WMI in the developing brain by inhibiting the expression of fgl2 and pro inflammatory mediators, suggesting that APC may be a potential therapeutic approach for intrauterine inflammation induced neonatal brain injury.",
  "reading_complete" : "2020-08-02T14:18:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:16:56Z",
  "trigger" : "attenuates",
  "evidence" : [ "APC attenuates fetal neuroinflammation and the associated secondary WMI in the developing brain by inhibiting the expression of fgl2 and pro-inflammatory mediators, suggesting that APC may be a potential therapeutic approach for intrauterine inflammation-induced neonatal brain injury" ],
  "pmc_id" : "4380123",
  "score" : 0
}